Navigation Links
Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
Date:2/20/2008

SAN DIEGO, Feb. 20 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report fourth quarter and full year 2007 financial results after the NASDAQ Global Market closes on Wednesday, February 27, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the financial results for the fourth quarter and full year 2007 and to provide 2008 financial guidance and a corporate update.

The conference call may be accessed by dialing 866.356.4281 for domestic callers and 617.597.5395 for international callers. Please specify to the operator that you would like to join the "Arena Fourth Quarter and Full Year Earnings Call." The participant code for the call is 19957700. The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds tar
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
3. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
4. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
5. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
6. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
9. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
11. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... ... its technology platform to support large projects. , ... (PRWEB) January 21, 2010 -- Firmex, the leader in ... to its technology platform. , , , , ,Firmex has released a new architecture ...
... ... development capacity drives PCT to open new facility , ... Allendale, NJ (Vocus) January 22, 2010 -- Progenitor Cell Therapy, LLC ... , , , , ,The company’s new cell therapy development and manufacturing ...
... ... SINGAPORE , January 22 , ... Together for Honors , Elsevier announced today the winners ... Scopus(R), the,world,s largest abstract and citation database of peer-reviewed literature,and the Third World ...
Cached Biology Technology:Firmex Announces Virtual Data Room Enhancements for Large Projects 2Firmex Announces Virtual Data Room Enhancements for Large Projects 3Progenitor Cell Therapy Expands Manufacturing Operations 2Progenitor Cell Therapy Expands Manufacturing Operations 3Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 2Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 3Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 4Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 5Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 6Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 7
(Date:4/15/2014)... deforestation could cause temperatures in the Congo Basin ... intensify warming caused by greenhouse gases by half, ... University of Leuven, Belgium. , Explosive population growth ... of tropical rainforests in Central Africa. A team ... how these practices will affect longer-term temperatures in ...
(Date:4/15/2014)... IL (April 15, 2014) New research published ... of the American College of Nutrition shows whey ... or as part of a weight-loss or weight-maintenance diet, ... composition. , The meta-analysis included 14 randomized controlled ... researchers analyzed those weight loss studies that used whey ...
(Date:4/14/2014)... the greenhouse gas methane were found above shale gas ... an important emissions source, according to a study jointly ... have implications for the evaluation of the environmental impacts ... one of only a few to use a so-called ... the air above wells, identified seven individual well pads ...
Breaking Biology News(10 mins):Study: Deforestation could intensify climate change in Congo Basin by half 2New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2
... African Americans known to potentially cause hypertension, found Michael ... in the September issue of Experimental Physiology. Brown is ... of Health Professions. The hormone, aldosterone, influences the ... it can contribute to the development of hypertension because ...
... Enjoying your August vacation? Well, (as they say in the ... has been consistently quiet, sudden, and deadly. Unknowingly, we have ... rock -- you personally are not in any danger. Its ... be an accomplice. Melodrama aside, the threat is very ...
... For years, scientists have known that some people are biologically ... only been able to speculate why. In the August ... the University of Chicago report on a study that may ... rats most likely to self-administer addictive drugs had a particular ...
Cached Biology News:Understanding hypertension in African Americans proves elusive 2Humans fostering forest-destroying disease 2Humans fostering forest-destroying disease 3Humans fostering forest-destroying disease 4Nicotinic receptors may be important targets for treatment of multiple addictions 2
... Combining linear motor and ballscrew ... pre-engineered Cartesian solutions that include ... management, and motors., , ... Pass through high-flex cabling for ...
UGT1A6 (D-20)...
... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
... designed for moving loads quickly and accurately. ... output while limiting overall size. The P5S-P ... ball bearings guided on two rails., ... provide energy absorption and controlled deceleration , ...
Biology Products: